Harvard renovates building to create new labs for stem-cell research

Harvard renews an older building to create new labs in Cambridge for stem-cell research.

A gut renovation of the Sherman Fairchild building this fall will yield 62,000 square feet of space for 275 investigators dedicated to stem-cell research, including faculty members, graduate students, technicians, postdoctoral fellows, and research assistants. The high-density open labs--211 net square feet per work station--are part of a design philosophy intended to foster collaboration that carries over from the unbuilt Allston science complex. When the $65-million to $70-million project is complete in the fall of 2011, there will be 16 faculty investigators engaged in stem-cell and regenerative biology in Cambridge here and in the adjacent Bauer Laboratory.

You might also like

Harvard’s Endowment, Donations Rise—but the University Runs a Deficit

The annual financial report signals severe challenges to come.

Harvard Alum Wins Economics Nobel Prize

Philippe Aghion helped show how “creative destruction” drives growth.

Harvard Football: Harvard 31, Merrimack 7

The Crimson stay unbeaten and uncover a new star.

Most popular

What Trump Means for John Roberts’s Legacy

Executive power is on the docket at the Supreme Court.

Harvard’s Class of 2029 Reflects Shifts in Racial Makeup After Affirmative Action Ends

International students continue to enroll amid political uncertainty; mandatory SATs lead to a drop in applications.

The Harvard Professor Who Quantified Democracy

Erica Chenoweth’s data shows how—and when—authoritarians fall.

Explore More From Current Issue

Aerial view of a landscaped area with trees and seating, surrounded by buildings and parking.

Landscape Architect Julie Bargmann Transforming Forgotten Urban Sites

Julie Bargmann and her D.I.R.T. Studio give new life to abandoned mines, car plants, and more.

Illustration of tiny doctors working inside a large nose against a turquoise background.

A Flu Vaccine That Actually Works

Next-gen vaccines delivered directly to the site of infection are far more effective than existing shots.